Global Radioactive Diagnostic Drugs Market Growth (Status and Outlook) 2026-2032

August 2026 | 85 pages | ID: G59A872A15C4EN
LP Information

Abstracts

The global Radioactive Diagnostic Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Radioactive Diagnostic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Radioactive Diagnostic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Radioactive Diagnostic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Radioactive Diagnostic Drugs players cover Curium, Medi-Radiopharma, Jubilant Radiopharma, Telix, Mallinckrodt, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Radioactive Diagnostic Drugs Industry Forecast? looks at past sales and reviews total world Radioactive Diagnostic Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Radioactive Diagnostic Drugs sales for 2026 through 2032. With Radioactive Diagnostic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioactive Diagnostic Drugs industry.

This Insight Report provides a comprehensive analysis of the global Radioactive Diagnostic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radioactive Diagnostic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Radioactive Diagnostic Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioactive Diagnostic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioactive Diagnostic Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Radioactive Diagnostic Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Single Photon Drugs
• Positron Drugs
• Blood Perfusion Drugs
• Metabolizing Drugs
• Receptor Binding Drugs
• Others

Segmentation by Application:

• Oncology
• Cardiology
• Neuroscience
• Thyroid
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Curium
• Medi-Radiopharma
• Jubilant Radiopharma
• Telix
• Mallinckrodt
• Cardinal Health
• Bayer AG
• GE Healthcare
• Mallinckrodt Pharmaceuticals
• Bracco Group

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Radioactive Diagnostic Drugs Market Size (2021-2032)
  2.1.2 Radioactive Diagnostic Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Radioactive Diagnostic Drugs by Country/Region (2021, 2025 & 2032)
2.2 Radioactive Diagnostic Drugs Segment by Type
  2.2.1 Single Photon Drugs
  2.2.2 Positron Drugs
  2.2.3 Blood Perfusion Drugs
  2.2.4 Metabolizing Drugs
  2.2.5 Receptor Binding Drugs
  2.2.6 Others
  2.2.7 Radioactive Diagnostic Drugs Market Size by Type
    2.2.7.1 Radioactive Diagnostic Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.7.2 Global Radioactive Diagnostic Drugs Market Size Market Share by Type (2021-2026)
2.3 Radioactive Diagnostic Drugs Segment by Application
  2.3.1 Oncology
  2.3.2 Cardiology
  2.3.3 Neuroscience
  2.3.4 Thyroid
  2.3.5 Others
  2.3.6 Radioactive Diagnostic Drugs Market Size by Application
    2.3.6.1 Radioactive Diagnostic Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.6.2 Global Radioactive Diagnostic Drugs Market Size Market Share by Application (2021-2026)

3 RADIOACTIVE DIAGNOSTIC DRUGS MARKET SIZE BY PLAYER

3.1 Radioactive Diagnostic Drugs Market Size Market Share by Player
  3.1.1 Global Radioactive Diagnostic Drugs Revenue by Player (2021-2026)
  3.1.2 Global Radioactive Diagnostic Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Radioactive Diagnostic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RADIOACTIVE DIAGNOSTIC DRUGS BY REGION

4.1 Radioactive Diagnostic Drugs Market Size by Region (2021-2026)
4.2 Global Radioactive Diagnostic Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radioactive Diagnostic Drugs Market Size Growth (2021-2026)
4.4 APAC Radioactive Diagnostic Drugs Market Size Growth (2021-2026)
4.5 Europe Radioactive Diagnostic Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Radioactive Diagnostic Drugs Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Radioactive Diagnostic Drugs Market Size by Country (2021-2026)
5.2 Americas Radioactive Diagnostic Drugs Market Size by Type (2021-2026)
5.3 Americas Radioactive Diagnostic Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Radioactive Diagnostic Drugs Market Size by Region (2021-2026)
6.2 APAC Radioactive Diagnostic Drugs Market Size by Type (2021-2026)
6.3 APAC Radioactive Diagnostic Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Radioactive Diagnostic Drugs Market Size by Country (2021-2026)
7.2 Europe Radioactive Diagnostic Drugs Market Size by Type (2021-2026)
7.3 Europe Radioactive Diagnostic Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Radioactive Diagnostic Drugs by Region (2021-2026)
8.2 Middle East & Africa Radioactive Diagnostic Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Radioactive Diagnostic Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RADIOACTIVE DIAGNOSTIC DRUGS MARKET FORECAST

10.1 Global Radioactive Diagnostic Drugs Forecast by Region (2027-2032)
  10.1.1 Global Radioactive Diagnostic Drugs Forecast by Region (2027-2032)
  10.1.2 Americas Radioactive Diagnostic Drugs Forecast
  10.1.3 APAC Radioactive Diagnostic Drugs Forecast
  10.1.4 Europe Radioactive Diagnostic Drugs Forecast
  10.1.5 Middle East & Africa Radioactive Diagnostic Drugs Forecast
10.2 Americas Radioactive Diagnostic Drugs Forecast by Country (2027-2032)
  10.2.1 United States Market Radioactive Diagnostic Drugs Forecast
  10.2.2 Canada Market Radioactive Diagnostic Drugs Forecast
  10.2.3 Mexico Market Radioactive Diagnostic Drugs Forecast
  10.2.4 Brazil Market Radioactive Diagnostic Drugs Forecast
10.3 APAC Radioactive Diagnostic Drugs Forecast by Region (2027-2032)
  10.3.1 China Radioactive Diagnostic Drugs Market Forecast
  10.3.2 Japan Market Radioactive Diagnostic Drugs Forecast
  10.3.3 Korea Market Radioactive Diagnostic Drugs Forecast
  10.3.4 Southeast Asia Market Radioactive Diagnostic Drugs Forecast
  10.3.5 India Market Radioactive Diagnostic Drugs Forecast
  10.3.6 Australia Market Radioactive Diagnostic Drugs Forecast
10.4 Europe Radioactive Diagnostic Drugs Forecast by Country (2027-2032)
  10.4.1 Germany Market Radioactive Diagnostic Drugs Forecast
  10.4.2 France Market Radioactive Diagnostic Drugs Forecast
  10.4.3 UK Market Radioactive Diagnostic Drugs Forecast
  10.4.4 Italy Market Radioactive Diagnostic Drugs Forecast
  10.4.5 Russia Market Radioactive Diagnostic Drugs Forecast
10.5 Middle East & Africa Radioactive Diagnostic Drugs Forecast by Region (2027-2032)
  10.5.1 Egypt Market Radioactive Diagnostic Drugs Forecast
  10.5.2 South Africa Market Radioactive Diagnostic Drugs Forecast
  10.5.3 Israel Market Radioactive Diagnostic Drugs Forecast
  10.5.4 Turkey Market Radioactive Diagnostic Drugs Forecast
10.6 Global Radioactive Diagnostic Drugs Forecast by Type (2027-2032)
10.7 Global Radioactive Diagnostic Drugs Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Radioactive Diagnostic Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Curium
  11.1.1 Curium Company Information
  11.1.2 Curium Radioactive Diagnostic Drugs Product Offered
  11.1.3 Curium Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Curium Main Business Overview
  11.1.5 Curium Latest Developments
11.2 Medi-Radiopharma
  11.2.1 Medi-Radiopharma Company Information
  11.2.2 Medi-Radiopharma Radioactive Diagnostic Drugs Product Offered
  11.2.3 Medi-Radiopharma Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Medi-Radiopharma Main Business Overview
  11.2.5 Medi-Radiopharma Latest Developments
11.3 Jubilant Radiopharma
  11.3.1 Jubilant Radiopharma Company Information
  11.3.2 Jubilant Radiopharma Radioactive Diagnostic Drugs Product Offered
  11.3.3 Jubilant Radiopharma Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Jubilant Radiopharma Main Business Overview
  11.3.5 Jubilant Radiopharma Latest Developments
11.4 Telix
  11.4.1 Telix Company Information
  11.4.2 Telix Radioactive Diagnostic Drugs Product Offered
  11.4.3 Telix Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Telix Main Business Overview
  11.4.5 Telix Latest Developments
11.5 Mallinckrodt
  11.5.1 Mallinckrodt Company Information
  11.5.2 Mallinckrodt Radioactive Diagnostic Drugs Product Offered
  11.5.3 Mallinckrodt Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Mallinckrodt Main Business Overview
  11.5.5 Mallinckrodt Latest Developments
11.6 Cardinal Health
  11.6.1 Cardinal Health Company Information
  11.6.2 Cardinal Health Radioactive Diagnostic Drugs Product Offered
  11.6.3 Cardinal Health Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Cardinal Health Main Business Overview
  11.6.5 Cardinal Health Latest Developments
11.7 Bayer AG
  11.7.1 Bayer AG Company Information
  11.7.2 Bayer AG Radioactive Diagnostic Drugs Product Offered
  11.7.3 Bayer AG Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Bayer AG Main Business Overview
  11.7.5 Bayer AG Latest Developments
11.8 GE Healthcare
  11.8.1 GE Healthcare Company Information
  11.8.2 GE Healthcare Radioactive Diagnostic Drugs Product Offered
  11.8.3 GE Healthcare Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 GE Healthcare Main Business Overview
  11.8.5 GE Healthcare Latest Developments
11.9 Mallinckrodt Pharmaceuticals
  11.9.1 Mallinckrodt Pharmaceuticals Company Information
  11.9.2 Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Product Offered
  11.9.3 Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Mallinckrodt Pharmaceuticals Main Business Overview
  11.9.5 Mallinckrodt Pharmaceuticals Latest Developments
11.10 Bracco Group
  11.10.1 Bracco Group Company Information
  11.10.2 Bracco Group Radioactive Diagnostic Drugs Product Offered
  11.10.3 Bracco Group Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Bracco Group Main Business Overview
  11.10.5 Bracco Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Radioactive Diagnostic Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Radioactive Diagnostic Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Photon Drugs
Table 4. Major Players of Positron Drugs
Table 5. Major Players of Blood Perfusion Drugs
Table 6. Major Players of Metabolizing Drugs
Table 7. Major Players of Receptor Binding Drugs
Table 8. Major Players of Others
Table 9. Radioactive Diagnostic Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Radioactive Diagnostic Drugs Market Size by Type (2021-2026) & ($ millions)
Table 11. Global Radioactive Diagnostic Drugs Market Size Market Share by Type (2021-2026)
Table 12. Radioactive Diagnostic Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Radioactive Diagnostic Drugs Market Size by Application (2021-2026) & ($ millions)
Table 14. Global Radioactive Diagnostic Drugs Market Size Market Share by Application (2021-2026)
Table 15. Global Radioactive Diagnostic Drugs Revenue by Player (2021-2026) & ($ millions)
Table 16. Global Radioactive Diagnostic Drugs Revenue Market Share by Player (2021-2026)
Table 17. Radioactive Diagnostic Drugs Key Players Head office and Products Offered
Table 18. Radioactive Diagnostic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Radioactive Diagnostic Drugs Market Size by Region (2021-2026) & ($ millions)
Table 22. Global Radioactive Diagnostic Drugs Market Size Market Share by Region (2021-2026)
Table 23. Global Radioactive Diagnostic Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 24. Global Radioactive Diagnostic Drugs Revenue Market Share by Country/Region (2021-2026)
Table 25. Americas Radioactive Diagnostic Drugs Market Size by Country (2021-2026) & ($ millions)
Table 26. Americas Radioactive Diagnostic Drugs Market Size Market Share by Country (2021-2026)
Table 27. Americas Radioactive Diagnostic Drugs Market Size by Type (2021-2026) & ($ millions)
Table 28. Americas Radioactive Diagnostic Drugs Market Size Market Share by Type (2021-2026)
Table 29. Americas Radioactive Diagnostic Drugs Market Size by Application (2021-2026) & ($ millions)
Table 30. Americas Radioactive Diagnostic Drugs Market Size Market Share by Application (2021-2026)
Table 31. APAC Radioactive Diagnostic Drugs Market Size by Region (2021-2026) & ($ millions)
Table 32. APAC Radioactive Diagnostic Drugs Market Size Market Share by Region (2021-2026)
Table 33. APAC Radioactive Diagnostic Drugs Market Size by Type (2021-2026) & ($ millions)
Table 34. APAC Radioactive Diagnostic Drugs Market Size by Application (2021-2026) & ($ millions)
Table 35. Europe Radioactive Diagnostic Drugs Market Size by Country (2021-2026) & ($ millions)
Table 36. Europe Radioactive Diagnostic Drugs Market Size Market Share by Country (2021-2026)
Table 37. Europe Radioactive Diagnostic Drugs Market Size by Type (2021-2026) & ($ millions)
Table 38. Europe Radioactive Diagnostic Drugs Market Size by Application (2021-2026) & ($ millions)
Table 39. Middle East & Africa Radioactive Diagnostic Drugs Market Size by Region (2021-2026) & ($ millions)
Table 40. Middle East & Africa Radioactive Diagnostic Drugs Market Size by Type (2021-2026) & ($ millions)
Table 41. Middle East & Africa Radioactive Diagnostic Drugs Market Size by Application (2021-2026) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Radioactive Diagnostic Drugs
Table 43. Key Market Challenges & Risks of Radioactive Diagnostic Drugs
Table 44. Key Industry Trends of Radioactive Diagnostic Drugs
Table 45. Global Radioactive Diagnostic Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 46. Global Radioactive Diagnostic Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 47. Global Radioactive Diagnostic Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 48. Global Radioactive Diagnostic Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 49. Curium Details, Company Type, Radioactive Diagnostic Drugs Area Served and Its Competitors
Table 50. Curium Radioactive Diagnostic Drugs Product Offered
Table 51. Curium Radioactive Diagnostic Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 52. Curium Main Business
Table 53. Curium Latest Developments
Table 54. Medi-Radiopharma Details, Company Type, Radioactive Diagnostic Drugs Area Served and Its Competitors
Table 55. Medi-Radiopharma Radioactive Diagnostic Drugs Product Offered
Table 56. Medi-Radiopharma Radioactive Diagnostic Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 57. Medi-Radiopharma Main Business
Table 58. Medi-Radiopharma Latest Developments
Table 59. Jubilant Radiopharma Details, Company Type, Radioactive Diagnostic Drugs Area Served and Its Competitors
Table 60. Jubilant Radiopharma Radioactive Diagnostic Drugs Product Offered
Table 61. Jubilant Radiopharma Radioactive Diagnostic Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Jubilant Radiopharma Main Business
Table 63. Jubilant Radiopharma Latest Developments
Table 64. Telix Details, Company Type, Radioactive Diagnostic Drugs Area Served and Its Competitors
Table 65. Telix Radioactive Diagnostic Drugs Product Offered
Table 66. Telix Radioactive Diagnostic Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Telix Main Business
Table 68. Telix Latest Developments
Table 69. Mallinckrodt Details, Company Type, Radioactive Diagnostic Drugs Area Served and Its Competitors
Table 70. Mallinckrodt Radioactive Diagnostic Drugs Product Offered
Table 71. Mallinckrodt Radioactive Diagnostic Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Mallinckrodt Main Business
Table 73. Mallinckrodt Latest Developments
Table 74. Cardinal Health Details, Company Type, Radioactive Diagnostic Drugs Area Served and Its Competitors
Table 75. Cardinal Health Radioactive Diagnostic Drugs Product Offered
Table 76. Cardinal Health Radioactive Diagnostic Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Cardinal Health Main Business
Table 78. Cardinal Health Latest Developments
Table 79. Bayer AG Details, Company Type, Radioactive Diagnostic Drugs Area Served and Its Competitors
Table 80. Bayer AG Radioactive Diagnostic Drugs Product Offered
Table 81. Bayer AG Radioactive Diagnostic Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Bayer AG Main Business
Table 83. Bayer AG Latest Developments
Table 84. GE Healthcare Details, Company Type, Radioactive Diagnostic Drugs Area Served and Its Competitors
Table 85. GE Healthcare Radioactive Diagnostic Drugs Product Offered
Table 86. GE Healthcare Radioactive Diagnostic Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. GE Healthcare Main Business
Table 88. GE Healthcare Latest Developments
Table 89. Mallinckrodt Pharmaceuticals Details, Company Type, Radioactive Diagnostic Drugs Area Served and Its Competitors
Table 90. Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Product Offered
Table 91. Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Mallinckrodt Pharmaceuticals Main Business
Table 93. Mallinckrodt Pharmaceuticals Latest Developments
Table 94. Bracco Group Details, Company Type, Radioactive Diagnostic Drugs Area Served and Its Competitors
Table 95. Bracco Group Radioactive Diagnostic Drugs Product Offered
Table 96. Bracco Group Radioactive Diagnostic Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Bracco Group Main Business
Table 98. Bracco Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Radioactive Diagnostic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radioactive Diagnostic Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Radioactive Diagnostic Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Radioactive Diagnostic Drugs Sales Market Share by Country/Region (2025)
Figure 8. Radioactive Diagnostic Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Radioactive Diagnostic Drugs Market Size Market Share by Type in 2025
Figure 10. Radioactive Diagnostic Drugs in Oncology
Figure 11. Global Radioactive Diagnostic Drugs Market: Oncology (2021-2026) & ($ millions)
Figure 12. Radioactive Diagnostic Drugs in Cardiology
Figure 13. Global Radioactive Diagnostic Drugs Market: Cardiology (2021-2026) & ($ millions)
Figure 14. Radioactive Diagnostic Drugs in Neuroscience
Figure 15. Global Radioactive Diagnostic Drugs Market: Neuroscience (2021-2026) & ($ millions)
Figure 16. Radioactive Diagnostic Drugs in Thyroid
Figure 17. Global Radioactive Diagnostic Drugs Market: Thyroid (2021-2026) & ($ millions)
Figure 18. Radioactive Diagnostic Drugs in Others
Figure 19. Global Radioactive Diagnostic Drugs Market: Others (2021-2026) & ($ millions)
Figure 20. Global Radioactive Diagnostic Drugs Market Size Market Share by Application in 2025
Figure 21. Global Radioactive Diagnostic Drugs Revenue Market Share by Player in 2025
Figure 22. Global Radioactive Diagnostic Drugs Market Size Market Share by Region (2021-2026)
Figure 23. Americas Radioactive Diagnostic Drugs Market Size 2021-2026 ($ millions)
Figure 24. APAC Radioactive Diagnostic Drugs Market Size 2021-2026 ($ millions)
Figure 25. Europe Radioactive Diagnostic Drugs Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Radioactive Diagnostic Drugs Market Size 2021-2026 ($ millions)
Figure 27. Americas Radioactive Diagnostic Drugs Value Market Share by Country in 2025
Figure 28. United States Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Radioactive Diagnostic Drugs Market Size Market Share by Region in 2025
Figure 33. APAC Radioactive Diagnostic Drugs Market Size Market Share by Type (2021-2026)
Figure 34. APAC Radioactive Diagnostic Drugs Market Size Market Share by Application (2021-2026)
Figure 35. China Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 39. India Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Radioactive Diagnostic Drugs Market Size Market Share by Country in 2025
Figure 42. Europe Radioactive Diagnostic Drugs Market Size Market Share by Type (2021-2026)
Figure 43. Europe Radioactive Diagnostic Drugs Market Size Market Share by Application (2021-2026)
Figure 44. Germany Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. France Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Radioactive Diagnostic Drugs Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Radioactive Diagnostic Drugs Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Radioactive Diagnostic Drugs Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Radioactive Diagnostic Drugs Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 58. APAC Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 59. Europe Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 61. United States Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 62. Canada Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 63. Mexico Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 64. Brazil Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 65. China Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 66. Japan Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 67. Korea Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 69. India Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 70. Australia Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 71. Germany Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 72. France Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 73. UK Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 74. Italy Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 75. Russia Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 76. Egypt Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 77. South Africa Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 78. Israel Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 79. Turkey Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)
Figure 80. Global Radioactive Diagnostic Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Radioactive Diagnostic Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Radioactive Diagnostic Drugs Market Size 2027-2032 ($ millions)